Korea SPAC 2 (206400) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Korea SPAC 2 (206400) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-771.01 Million ≈ $-522.50K USD) by net assets (₩77.84 Billion ≈ $52.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Korea SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Korea SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Korea SPAC 2 (206400) total liabilities for a breakdown of total debt and financial obligations.
Korea SPAC 2 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Korea SPAC 2 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Microba Life Sciences Ltd
AU:MAP
|
-0.287x |
|
DLP Resources Inc
V:DLP
|
-0.296x |
|
Lipum AB
ST:LIPUM
|
1.465x |
|
FreeMs Corporation
KQ:053160
|
0.004x |
|
Globus Maritime Ltd
NASDAQ:GLBS
|
0.020x |
|
Havila Shipping ASA
OL:HAVI
|
0.404x |
|
S Connect Co. LTD
KQ:096630
|
0.027x |
|
Berentzen Gruppe AG
XETRA:BEZ
|
0.372x |
Annual Cash Flow Conversion Efficiency for Korea SPAC 2 (2015–2024)
The table below shows the annual cash flow conversion efficiency of Korea SPAC 2 from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Korea SPAC 2 stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩95.22 Billion ≈ $64.53 Million |
₩-3.71 Billion ≈ $-2.52 Million |
-0.039x | +13.60% |
| 2023-12-31 | ₩79.90 Billion ≈ $54.15 Million |
₩-3.60 Billion ≈ $-2.44 Million |
-0.045x | -164.00% |
| 2022-12-31 | ₩69.94 Billion ≈ $47.40 Million |
₩4.93 Billion ≈ $3.34 Million |
0.070x | +187.80% |
| 2021-12-31 | ₩84.87 Billion ≈ $57.51 Million |
₩2.08 Billion ≈ $1.41 Million |
0.024x | +132.06% |
| 2020-12-31 | ₩50.47 Billion ≈ $34.20 Million |
₩-3.86 Billion ≈ $-2.61 Million |
-0.076x | -229.49% |
| 2019-12-31 | ₩33.77 Billion ≈ $22.89 Million |
₩1.99 Billion ≈ $1.35 Million |
0.059x | +103.11% |
| 2018-12-31 | ₩6.79 Billion ≈ $4.60 Million |
₩-12.87 Billion ≈ $-8.72 Million |
-1.897x | -125.27% |
| 2017-12-31 | ₩13.25 Billion ≈ $8.98 Million |
₩-11.16 Billion ≈ $-7.56 Million |
-0.842x | -182.09% |
| 2016-12-31 | ₩16.74 Billion ≈ $11.34 Million |
₩-5.00 Billion ≈ $-3.39 Million |
-0.298x | -132.76% |
| 2015-12-31 | ₩22.48 Billion ≈ $15.24 Million |
₩-2.88 Billion ≈ $-1.95 Million |
-0.128x | -- |
About Korea SPAC 2
BENO TNR, Inc. engages in interior design, construction, robot, and bio businesses. It engages in the designing, manufacturing, and construction of shading systems, eco-friendly flooring, and radiant heating panels applied to various buildings. It also provides XoMotion, an exoskeleton wearable robot that supports lower body movements; and develops medicine through epigenetic modification. BENO T… Read more